Elicio Therapeutics Inc (ELTX)

Finanzdaten der Elicio Therapeutics Inc-Aktie (ELTX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	0.80%6.81	6.76	5.08	5.04	7.01
Research and Development	0.80%6.81	6.76	5.08	5.04	7.01
Costs And Expenses	1.63%10.43	10.60	8.84	8.05	10.09
Operating Income/Loss	1.63%-10.43	-10.60	-8.84	-8.05	-10.09
Nonoperating Income/Loss	281.16%2.21	-1.22	1.12	-2.04	-0.47
Income Tax Expense/Benefit	-	-	-	-	-
	30.50%-8.22	-11.82	-7.72	-10.08	-10.56
Attributable To Parent	30.50%-8.22	-11.82	-7.72	-10.08	-10.56
Basic Average Shares	5.67%19.24	18.21	-	16.69	16.06
Diluted Average Shares	5.67%19.24	18.21	-	16.69	16.06
Basic Earnings Per Share	33.85%-0.43	-0.65	-	-0.60	-0.66
Diluted Earnings Per Share	33.85%-0.43	-0.65	-	-0.60	-0.66